Mitotech LLC is the hub company of biotech project "Skulachev ions". The company goal is to develop and market set of innovative pharmaceuticals based on new type of biologically active compounds - mitochondrially targeted antioxidants SkQ. Investors of the company is RUSNANO (Russian state corporation of nanotechnologies - www.rusnano.com) and Rostok Group (private foundation - www.grostok.ru).
| Website | http://mitotechpharma.com |
| Revenue | $8.2 million |
| Employees | 10 (10 on RocketReach) |
| Founded | 2009 |
| Phone | (505) 670-0232 |
| Technologies |
HTML
,
Google Analytics
,
Google Tag Manager
+5 more
(view full list)
|
| Industry | Biotechnology, Biotechnology Research, Drug Stores & Pharmacies, Retail, Science and Engineering, Nanobiotechnology, Drug development, R&D in Biology and Medicine |
| Web Rank | 16 Million |
| Keywords | Drug Development, Pharmaceutical Development, Innovative Drugs, Therapeutics, Innovative Therapeutics, Drug Discovery, Bioactive Molecules, New Drugs, Antioxidants, New Therapies, Biotech, Medical Research, Clinical Trials |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, AstraZeneca, Novartis, Regeneron, Receptos, a wholly-owned subsidiary of Celgene, Lilly India +42 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 28 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies |
Looking for a particular Mitotech LLC employee's phone or email?
Mitotech LLC Questions
The Mitotech LLC annual revenue was $8.2 million in 2026.
Natalia Perekhvatova is the CEO of Mitotech LLC.
10 people are employed at Mitotech LLC.
The NAICS codes for Mitotech LLC are [3254, 32, 32541, 325].
The SIC codes for Mitotech LLC are [283, 28].
Top Mitotech LLC Employees
-
Natalia Perekhvatova
CEO at Mitotech LLC
London, GB32 -
Maxim Skulachev
Chief Scientific Officer at Mitotech LLC
Moscow, Moscow, Russia32 -
Anton Petrov
Chief Operations Officer at Mitotech LLC
United Kingdom31 -
1
Related Companies
